ANN ARBOR, Mich., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of autologous adult stem cell treatments for severe chronic cardiovascular diseases, today announced that George Dunbar, President and Chief Executive Officer, and Elmar Burchardt, MD, PhD, Vice President, Medical Affairs, will present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference. The conference will be held on Wednesday, August 5th at the Millennium Broadway Hotel in New York City. Aastrom will present at 8:00 a.m. (Eastern Time).
